Lim, Ren Jun

Ren Jun Lim

Associate Principal
Wong & Leow LLC


Ren Jun Lim is an Associate Principal with Baker McKenzie Wong & Leow. He represents local and international clients in both contentious and non-contentious intellectual property matters. He also advises on a full range of healthcare, as well as consumer goods-related legal and regulatory issues.

Ren Jun sits on the Firm’s Asia Pacific Healthcare Group's Steering Committee and Leadership Team. He is a member of the Firm's Asia Pacific Healthcare Group's Compliance; ASEAN Economic Community; Product Liability; and Regulatory Sub-Committees. He is also a member of the Firm’s Asia Pacific Intellectual Property Group’s Anti-Counterfeiting Sub-Committee.

Practice Focus

Ren Jun represents local and international intellectual property-intensive clients in contentious and non-contentious matters.  These matters include civil and criminal litigation for all forms of intellectual property infringement; border enforcement; local and international filing and prosecution strategies; domain name disputes; opposition and revocation actions; general litigation; and anti-corruption issues.

In addition, Ren Jun plans and executes anti-counterfeiting operations for various clients in Singapore and around the Asia Pacific region.

Ren Jun also advises on various intellectual property-related and non-intellectual property-related commercial issues arising from mergers and acquisitions; licensing; franchising; data protection; due diligence; audits; and valuation.

He also assists clients on a wide spectrum of regulatory issues affecting the consumer goods industry such as licensing; advertising; trade libel; harassment; and product liability/recall.

In addition, Ren Jun keenly advises on a full range of issues relating to the healthcare industry. These include regulatory compliance in respect of drugs, medical devices, health supplements, food products and cosmetics; clinical trials; product liability/recall issues; data exclusivity; patent linkage; competition; and anti-corruption issues.

Representative Legal Matters

  • Acted for Clinique Laboratories LLC in a trade mark infringement and passing off action in the Singapore High Court, and the subsequent appeal in the Singapore Court of Appeal. This is a landmark case in which the Singapore courts ruled a trade mark to be well known to the public at large.

  • Acted for Seiko Holdings Corporation in a trade mark opposition action in the Intellectual Property Office of Singapore. This was the first occasion where the Intellectual Property Office of Singapore declared a trade mark to be well known to the public at large.

  • Acted for IMS Health in a breach of confidence action against three ex-employees and a rival company. Successfully obtained an interlocutory injunction from the Singapore High Court to keep the defendants from using the misappropriated confidential information.

  • Successfully executed anti-counterfeiting and border enforcement programs for various clients, including leading fashion and fragrance brands, global media and entertainment conglomerates, leading medical device companies, and multinational toy and board game companies.

  • Successfully executed a criminal search and seizure warrant on behalf of Solta Medical against an importer/distributor of counterfeit Thermage machines. Successfully persuaded the Health Sciences Authority to execute island-wide ex-officio raids against 16 beauty salons and spas that dealt with such machines.

  • Acted for a global pharmaceutical company against dealers of patent-infringing active pharmaceutical ingredients of sexual enhancement drugs.

  • Advised Kirin Holdings Company Limited (Kirin) on IP due diligence and licensing issues arising from OUE Baytown Pte Ltd's USD10.5 billion voluntary takeover of Fraser and Neave Ltd (F&N), and Kirin's USD1.62 billion purchase of F&N's food and beverage business.

  • Led cross-border teams throughout the Asia Pacific in advising on various corporate, regulatory, tax and IP issues arising from Ortho Clinical Diagnostics' USD4.15 billion divestiture from an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturer.

  • Advising a leading dairy cooperative on queries from the Competition Commission of Singapore, and on compliance risks arising from its sponsorship arrangements with hospitals.

  • Advised on cross-border product liability and recall issues for various clients, including medical devices manufacturers (for supply of unregistered medical devices); toy manufacturers (for defective toy products that contained excessive phthalate); electronic product manufacturers (for potentially defective products); as well as food and beverage, confectionery, spirits producers (for defective/wrongly labelled products).

Professional Associations and Memberships

  • Law Society of Singapore - Member

  • Singapore Academy of Law - Member

  • Regulatory Affairs Professionals Association - Member


  • Singapore (2009)


  • National University of Singapore (2008)


  • English
  • Mandarin

Previous Offices

  • Hong Kong